Single-dose therapeutic interfering particle lowers SARS-CoV-2 pathogenesis and shedding among hamsters

Researchers reported that a single-dose therapeutic interfering particle (TIP) lowers SARS-CoV-2 pathogenesis and shedding among hamsters.

COVID-19—from mucosal immunology to IBD patients - Mucosal Immunology

Identification of a therapeutic interfering particle—A single-dose SARS-CoV- 2 antiviral intervention with a high barrier to resistance - ScienceDirect

Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection

Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences

Full article: Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters

Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities

SARS-CoV-2: The Virus, Its Biology and COVID-19 Disease-Counteracting Possibilities

The Sleep-Immune Crosstalk in Health and Disease

Recent advances in developing small-molecule inhibitors against SARS-CoV-2 - ScienceDirect

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

SARS-CoV-2 Antiviral Therapy Clinical Microbiology Reviews

Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models - eBioMedicine

From Ancient to Emerging Infections: The Odyssey of Viruses in the Male Genital Tract

A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters. - Abstract - Europe PMC

Comprehensive role of SARS‐CoV‐2 spike glycoprotein in regulating host signaling pathway - Banerjee - 2022 - Journal of Medical Virology - Wiley Online Library